This article reviews the pharmacology, clinical efficacy, safety, dosing, drug-drug interactions, and implications for advanced practitioners of BTK inhibitors in the treatment of B-cell malignancies.

Click the link below to read the full article:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163255/